American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

AHPA issues cannabis oversight recommendations for regulators

Oversight framework promotes best practices for cannabis production and distribution from seed to consumption

The American Herbal Products Association (AHPA) has published recommendations for regulators to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

AHPA Calls for Withdrawal of "Hugely Flawed" NDI Notification Guidance in Comments to FDA

AHPA requests FDA to issue new guidance

The American Herbal Products Association (AHPA), in comments filed with the Food and Drug Administration (FDA), called for the agency to withdraw what it called the "hugely flawed" "Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues."
RSS
1234567

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.